The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy

被引：0
|
作者：
Sen, Saniye
Ustundag, Sedat
Gonlusen, Gulfiliz
Kanter, Mehmet
Dogutan, Haluk
Ciftci, Senturk
机构：
[1] Trakya Univ, Fac Med, Edirne, Turkey
[2] Cukurova Univ, Fac Med, Adana, Turkey
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [21] The effect of combining angiotensin receptor blocker and angiotensin converting enzyme inhibitor on albuminuria in Type 2 diabetic patients with nephropathy
    Tan, F
    Liew, S
    Mukherjee, JJ
    Lee, KO
    Lim, P
    DIABETOLOGIA, 2004, 47 : A386 - A386
  • [22] Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats
    Yamada, T
    Kuno, A
    Ogawa, K
    Tang, MX
    Masuda, K
    Nakamura, S
    Ando, T
    Okamoto, T
    Ohara, H
    Nomura, T
    Joh, T
    Shirai, T
    Itoh, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01): : 36 - 45
  • [23] Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination Therapy Better Than Monotherapy and Safe in Patients With CKD?
    Berns, Jeffrey S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (02) : 192 - 196
  • [24] Retrospective Review of Exceptions for Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Recommendations for a Diabetic Medicare Population
    Chinthammit, Chanadda
    Harrington, Amanda
    Wild, Ann
    Werner, Shepin
    Boesen, Kevin
    Taylor, Ann M.
    Warholak, Terri L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (03): : 358 - +
  • [25] Effects of angiotensin-converting enzyme inhibitors or an angiotensin receptor blocker in combination with aspirin and cilostazol on in-stent restenosis
    Ujiie, Y
    Hirosaka, A
    Mitsugi, M
    Ohwada, T
    Igarashi, M
    Kijima, M
    Komatsu, N
    Hisa, S
    Abe, Y
    Tsuda, T
    Yaoita, H
    Maehara, K
    Maruyama, Y
    INTERNATIONAL HEART JOURNAL, 2006, 47 (02) : 173 - 184
  • [26] Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer
    Tuazon, Sherilyn Alvaran
    King, Gantry Teng
    Cruz, Joanna Sta.
    Chae, Young K.
    Koc, Jean B. Ong Klan
    Hegarty, Sarah
    Leighton, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
    Chu, Chi D.
    Powe, Neil R.
    Estrella, Michelle M.
    Shlipak, Michael G.
    McCoy, Ian E.
    Tuot, Delphine S.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (11) : 2099 - 2106
  • [28] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [29] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058
  • [30] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
12345